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Abstract
Background: Hospital Associated infections (HAI) are very common in Intensive Care Units (ICU) and are usually
associated with use of invasive devices in the patients. This study was conducted to determine the prevalence and
etiological agents of HAI in a Surgical ICU in Kazakhstan, and to assess the impact of these infections on ICU stay
and mortality.
Objective: To assess the rate of device-associated infections and causative HAI etiological agents in an ICU at the
National Research Center for Oncology and Transplantation (NRCOT) in Astana, Kazakhstan.
Methods: This retrospective, observational study was conducted in a 12-bed ICU at the NRCOT, Astana, Kazakhstan.
We enrolled all patients who were admitted to the ICU from January, 2014 through November 2015, aged 18 to 90
years of age who developed an HAI.
Results: The most common type of HAI was surgical site infection (SSI), followed by ventilator-associated
pneumonia (VAP), catheter-related blood stream infection (BSI) and catheter-associated urinary tract infection
(UTI). The most common HAI was SSI with Pseudomonas aeruginosa as the most common etiological agent.
The second most common HAI was VAP also with P. aeruginosa followed by BSI which was also associated
with P. aeruginosa (in 2014) and Enterococcus faecalis, and Klebsiella pneumoniae (in 2015) as the most common
etiological agents causing these infections.
Conclusion: We found that HAI among our study population were predominantly caused by gram-negative
pathogens, including P. aeruginosa, K. pneumoniae, and E. coli. To our knowledge, this is the only study that
describes ICU-related HAI situation from a country within the Central Asian region. Many developing countries
such as Kazakhstan lack surveillance systems which could effectively decrease incidence of HAIs and healthcare costs
for their treatment. The epidemiological data on HAI in Kazakhstan currently is underrepresented and poorly reported
in the literature. Based on this and previous studies, we propose that the most important interventions to prevent HAI
at the NRCOT and similar Healthcare Institutions in Kazakhstan are active surveillance, regular infection control audits,
rational and effective antibacterial therapy, and general hygiene measures.
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Background
HAI influence the quality of health care and are a major
source of adverse outcomes during health care delivery
[1, 2]. HAI greatly increase morbidity and mortality of
patients and healthcare costs [3]. The burden of HAI in
developing countries is significant, whereby the inci-
dence can be up to 15% of total hospitalized patients,
and up to 50% among ICU patients [4]. HAI are challen-
ging to treat because the etiological agents frequently
develop multidrug, extensively drug and pandrug-
resistance [5]. HAI have a big economic impact on
healthcare by extending ICU stay, hospital stay, and in-
creasing the need for invasive procedures. The most
common HAI are primary bloodstream infections (BSI),
ventilator-associated pneumonia (VAP), urinary tract in-
fections (UTI) and surgical site infections (SSI), with SSI
being the most prevalent in some studies [2, 6]. Preven-
tion programs for HAI which could result in positive
cost-benefit ratios typically originate with laboratory data
from the clinical microbiology laboratory; this provides
information regarding the causative pathogenic organ-
isms causing the HAI [6].
The incidence of HAI in ICUs is about 2 to 5 times
higher than those in general inpatient departments due
to many associated risk factors [1, 7]. Furthermore, anti-
microbial resistance rates in ICU are much greater than
in general departments [7]. In order to reduce incidence
of HAI, surveillance analysis is an essential step to iden-
tify problems and implement interventions [8]. National
surveillance data form the basis for prevention and con-
trol of HAI in developed countries such as the USA and
Australia, but this is rarely available in many developing
countries, including Kazakhstan [9]. A recent system-
atic meta-analysis of the burden of HAI in Southeast
Asia found that the most common HAI pathogens were
mostly gram-negative bacilli, and were predominantly
Pseudomonas aeruginosa, Klebsiella species and Acine-
tobacter baumannii; these findings are similar to those
reported for many other developing countries [9].
According to the National Healthcare Safety Network
(NHSN) report in 2013, ICU-related central-line associ-
ated BSI continued to decrease, whereas urinary
catheter-associated tract infection rates increased in the
majority of ICU types [10]. Several studies conducted
in developing countries similar to ours, reported their
findings in the literature; one study from Kuwait re-
ported that their VAP rate was 4.0 per 1000 mechanical
ventilator days, the central line–associated BSI rate was
3.5 per 1000 central line days, and the catheter-
associated urinary tract infection (CAUTI) rate was 3.3
per 1000 urinary catheter days [11]. Another study
from Ecuador showed that device associated HAIs rates
in their ICUs were higher than the United States CDC/
NSHN rates and similar to International Nosocomial
Infection Control Consortium (INICC) international
rates [12].
In an effort to evaluate the local HAI situation in
Kazakhstan, we conducted an observational case study
to assess incidence of the different types of HAI over a
period of two years in 2014 and 2015. Our goal was to
investigate if the patterns regarding type of HAI cases
and the etiological agents were consistent from year to
year, therefore we performed an analysis and compari-
son of data from at least two years. The data from the
study was retrospectively analyzed in our effort to iden-
tify the causative HAI bacterial pathogens. We aimed
to assemble and analyze epidemiological data associated
with four different types of device associated HAI in an
ICU at the National Research Center for Oncology and
Transplantation (NRCOT) in Astana, Kazakhstan. The
information summarized here will form the basis for a
much larger surveillance study that could guide deci-
sions regarding appropriate and potentially more effica-
cious use of prophylactic control within the ICU. This
study could also guide the establishment of a national
surveillance program to control and prevent HAI in
hospitals in Kazakhstan and worldwide.
Methods
This retrospective, observational study was conducted
from January 2014 through January 2016 in a 12 bed
ICU at the National Research Center for Oncology and
Transplantation (NRCOT), which is a 280-bed hospital
in Astana, Kazakhstan. We undertook this pilot study
comparing HAI cases and causative agents over a two
year period to assess the current local infection control
practices. We hope to understand from this study if
intervention in the future would be appropriate to im-
prove upon the current HAI scenario. The main change
between 2014 and 2015 was access to better diagnostic
capabilities within the hospital laboratory, though there
are future plans to implement an improved HAI preven-
tion program. This was considered by us to be a “retro-
spective” study because data analysis on the most part
was done after these were collected (even though the
staff collected the data during the patients’ ICU visit). A
standard screening protocol for HAI was used [13]. We
tested all patients who spent more than 48 h in the ICU
(whereby, all patients with less than 48 h stay in the ICU
were excluded from this study). Samples for microbio-
logical culture and analysis were obtained from patients
who presented with HAI symptoms. Blood count,
blood biochemistry, and blood coagulation tests were
performed on all suspected patients who were at high
risk of developing HAI following guidelines provided
by the Healthcare Infection Control Practices Advisory
Committee [14]. Clinical Pharmacologist and Hospital
Infection Specialists visited the ICU every day. Chest
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radiography, deep tracheal aspirate, bronchoalveolar lav-
age (BAL) or mini-broncho-alveolar lavage (mini-BAL)
were taken for pathogen identification if VAP was sus-
pected. Blood samples, removed intravascular catheters,
urine, urinary and wound catheters were also cultured for
microbiological analysis if BSI, UTI or SSI were suspected.
Samples were cultured using standard microbiological
methods; isolated bacteria were identified by standard
microbiological methods and tested for antibiotic suscep-
tibility using Kirby-Bauer disk-diffusion technique ac-
cording to Clinical and Laboratory Standards Institute
(CLCI) specifications [15, 16].
Study ethics
Ethical clearance for this study was obtained from the
Ethics committee of the Institutional Review Board of
Nazarbayev University. The study was exempt from be-
ing classified as human subject research as no personal
information related to any of the patients was made
available to the Investigators at any time before, during
or after the study.
Study population and microbiological culture and
analysis
The patients admitted to the NRCOT ICU were from
different surgical departments, which included the de-
partment of general, oncology, transplant, vascular,
orthopedic, and gynecology surgeries. The patients with
a diagnosis of HAI received treatment according to the
hospital’s standard protocol of management of HAI.
Samples were taken from all patients admitted to the
ICU aged 18 to 90 years of age who developed HAI
based on clinical, laboratory and instrumental findings
throughout the study duration. For microbiological cul-
ture and sensitivity testing, lower respiratory tract secre-
tion, blood and urine samples were taken for diagnosis
of VAP, catheter-related BSI, and catheter-associated
UTI. Blood culture diagnostics was done for all samples
from patients with suspected catheter-related blood
stream infections. Data relevant to the diagnosis of HAI
were taken by the hospital staff, but only microbiological
data regarding etiological agents related to device associ-
ated HAI were provided for analysis in this study.
Statistical analysis
The rates of development of each type of HAI (BSI, VAP,
UTI and SSI) as well as the total rate per 1000 cases
were calculated. Relative risk for these groups was
assessed using StataMP 13.0 software, and statistically
significant cutoff was determined at a p-value of < 0.05,
and highly statistically significant cutoff at a p-value of
< 0.001. Prevalence of certain isolated strains of bacteria
that caused hospital-acquired infections for each year
was determined in percent and compared between the
years 2014 and 2015 using Chi-square analysis in
StataMP 13.0 software. Statistically significant level was
determined at a p-value < 0.05; and highly statistically
significant level at a p-value of < 0.001.
Results
General overview of ICU patients and the proportions
with HAI
A total number of 1257 patients were admitted to the
ICU from January 2014 to January 2016 of which, 56.6%
(711 patients) were admitted in 2014 compared to the
remaining 43.4% (546 patients) in 2015. The mean num-
ber of ICU stay was 18 days (with a range of 1–330 days)
in 2014, while in 2015 the mean ICU stay was 36 days
(with a range of 12–62 days); these variations are also a
reflection of some changes in perioperative care that
took place in between these two time periods. The
change we mention here that led to increased mean
number of ICU stay in 2015 compared to 2014 was due
to the change in patient population. In 2014, the patient
population consisted of patients who were transferred to
the ICU after emergency surgeries (which were more
than 85% of all transfers to ICU) such as patients who
underwent appendectomy, cholecystectomy, hernia re-
pair surgeries, etc. In 2015, the ICU patient population
consisted of patients who were transferred to the ICU
after oncological surgery (50%) and transplant surgery
(30%). The period of ICU stay of patients after emer-
gency surgery was generally shorter than the patients
who were moved to the ICU after oncological or trans-
plant surgery. Overall, the patients’ general health condi-
tions were better for the patients in 2014.
During the study period, 249 out of 1257 patients
admitted to the ICU developed HAI; the p-value for
the development of HAI between 2014 and 2015 was
0.000127 which is highly statistically significant. A
total of 114 microbiological cultures were obtained
and identified from patients suspected to have had
HAI in 2014 compared to 135 cultures isolated in 2015
(with a p-value of 0.6582 which is not significant).
Device associated infections
The HAIs were classified into four categories: BSI,
VAP, UTI and SSI. As evident from the Table 1, in
2014, SSI constituted the highest percentages of all
HAIs followed by VAP, BSI and UTI. When compared
to 2014, similar profile of device associated HAIs
were observed for 2015, whereby SSI was again the
most prominent category that caused HAI, followed
by VAP. However in 2015, the percent of observed
BSI was equal to the percent of UTI as the least fre-
quent types of HAI.
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Variation in types of infections
Analysis of HAI categories (BSI, VAP, UTI, and SSI)
in 2014 compared to 2015 was conducted and re-
vealed significant variation between certain types of
HAI (Fig. 1). Specifically, rates of VAP and SSI were
found to be statistically different (p-value < 0.05) be-
tween the two years of the study period. Rates of
VAP infections were higher in 2015 than in 2014. Similar
results were obtained for SSI, whereby the rate of infection
was again higher in 2015 (p-value < 0.05). On the other
hand, no difference in rates of BSI and UTI was observed.
The total rate of all types of infections was found to be
significantly higher in 2015 when compared to the
total infection rate in 2014 (p-value < 0.05). Data was
available for the VAP incidence which was determined
to be 8.4 per 1000 ventilator days while the incidence
of catheter-related blood stream infections was 18 per
1000 line days.
Microbiological etiology of HAI
A total number of 249 microbial pathogens were isolated
and identified in 2014 and 2015, and the percent
distribution of these etiological agents is represented in
Fig. 2a and b. The highest percent in 2014 corresponded
to Pseudomonas aeruginosa at 23.68%, which was slightly
reduced in 2015 to 13.33%. Klebsiella pneumoniae, Escher-
ichia coli, Staphylococcus aureus, Staphylococcus epider-
midis, and Acinetobacter baumannii were isolated and
identified from many HAI cases for both 2014 and 2015.
Unique and relatively widespread isolate for 2014 was
Enterobacter aerogenes, representing 17.54% of the cases.
Bacterial strains that had an incidence of less than 5%
were combined into the subgroup ‘Others’. In 2014
Streptococcus viridans, Citrobacter spp., Enterococcus fae-
cium, Achromobacter spp., Staphylococcus saprophyticus,
Candida albicans and Serratia spp. were included in this
subgroup. In 2015 however, in addition to the above-
mentioned Citrobacter spp., S. saprophyticus and C.
albicans, unique pathogens such as Staphylococcus
haemolyticus, Enterococcus cloacae, Candida tropicalis,
Burkholderia cepacia, Streptococcus mitis and Stenotro-
phomonas maltophilia were isolated. When comparison
analysis was conducted, highly significant difference be-
tween two years (p-value < 0.001) was identified. Even
though many strains were similar for both years, case-
wise analysis revealed important differences that should
be taken into account. The types of pathogen described
originated from cultures isolated from the different
HAI categories as shown in Fig. 3a (VAP), Fig.3b (BSI),
Fig. 3c (UTI), and Fig. 3d (SSI), and represented as percent
(%) of total number of organisms isolated. We found that
Table 1 Types of Hospital Associated infections in percent for
each year
Type of infection Percent in 2014
(total number)
Percent in 2015
(total number)
BSI 24.6% (28) 18.5% (25)
VAP 25.4% (29) 29.6% (40)
UTI 19.3% (22) 18.5% (25)
SSI 30.7% (35) 33.3% (45)
Total 100% (114) 100% (135)
BSI: Catheter-associated Blood Stream Infections, VAP: Ventilator-associated
Pneumonia, UTI: Catheter-associated Urinary Tract Infections, SSI: Surgical
Site Infections
Fig. 1 Samples for microbiological culture and analysis were obtained from patients who presented with HAI symptoms. Blood samples, removed
intravascular catheters, urine, urinary and wound catheters were also cultured for microbiological analysis if BSI, UTI or SSI were suspected. Comparison
of rates of case-specific infections between 2014 and 2015 were performed. Statistically significant level was determined at a p-value < 0.05; and highly
statistically significant level at a p-value of < 0.001. Statistically significant difference is noted for VAP, SSI and combined total between years 2014 and
2015 (statistical significance: *p-value< 0.05; **p-value< 0.001)
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Fig. 2 Samples for bacterial culture and analysis were obtained from patients who presented with HAI symptoms. Samples were cultured using
standard microbiological methods; isolated bacteria were identified by standard microbiological methods according to Clinical and Laboratory
Standards Institute (CLCI) specifications [12, 13]. For comparison, Chi-square test was conducted with a p-value < 0.001**. The subgroup ‘Others’
includes rare strains of bacteria (with incidence of < 5%), which were different for each year (comparing 2014 and 2015).
a
b
c
d
Fig. 3 The types of HAI pathogens shown in Fig. 2 were subdivided into the types of HAI samples they were isolated from; a VAP, b BSI, c UTI,
and d SSI and represented as percent (%) of total number of bacteria isolated. Samples were cultured using standard microbiological methods; isolated
bacteria were identified by standard microbiological methods according to Clinical and Laboratory Standards Institute (CLCI) specifications [12, 13]
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HAI were predominantly caused by gram-negative bacter-
ial pathogens, particularly P. aeruginosa and K. pneumo-
niae. These strains were most frequently associated with
all the HAI types particularly SSI and BSI (as the first two
most common types of HAI pathogens isolated) though
there are some variations between the two years with
these two pathogens as well as other types of bacterial
pathogens that predominated, such as Staphylococcus
epidermidis, E. faecalis and Acinetobacter baumannii.
From our study, P. aeruginosa was recognized as a
causal agent of the most serious HAI in the ICU. This
organism was also causing the majority of VAP and
BSIs in two consecutive years. SSI analogously was
mainly caused by gram-negative bacteria, of which P. aer-
uginosa prevailed in 2014, while K. pneumoniae predomi-
nated in 2015.
Discussion
In this study, we have shown that healthcare-associated
infections constitute a major healthcare burden in
Kazakhstan, which is a rapidly developing nation.
Kazakhstan is one of the five Central Asian countries
(which also include Kyrgyzstan, Tajikistan, Turkmenistan
and Uzbekistan) that achieved independence in 1991 after
the collapse of the Soviet Union [17, 18]. At independence,
these Central Asian Post-Soviet (CAPS) countries were
faced with many problems; progress to build stronger
economies varies between countries. Collapse of the Soviet
Union led Kazakhstan as well as the other CAPS countries
to economic recession. During the Soviet Union era, there
were no wide informational, medical and pharmaceutical
exchanges with other countries. On the other hand, the
dissolution of the Soviet Union mobilized these countries
to democracy which initiated important exchanges of
products and knowledge with the other countries. Greater
successes have been noted for Kazakhstan, Turkmenistan
and Uzbekistan, which are the CAPS countries with the
richest natural resources [17]. The healthcare systems of
these CAPS countries have also gone through many de-
cades of profound revolutions, whereby the rate and qual-
ity of progress of the healthcare sectors vary between these
countries [19]. Since independence, the CAPS countries
have steadily been receiving more attention at the inter-
national arena, especially due to the economic and geo-
graphical significance of the region. Over the last two
decades, Kazakhstan has made significant progress in
economy as well as healthcare sector, although there is still
much room for improvement.
To our knowledge, this is the only study to be re-
ported in an international journal describing ICU-
related HAI situation from the Central Asian region. In
our study, HAI represents a significant healthcare prob-
lem with ICU related HAI incidence being about 2 to 5
times higher than the incidence in other in-hospital
departments [7]. In our study, patients frequently had
the following universal host-related risk factors predis-
posing to HAI which included advanced age, severity of
disease, hyperglycemia, neutropenia, immunosuppressive
therapy, cancer diagnosis, and malnutrition. Majority of
the patients had at least three of these risk factors. The
most common type of HAI in our study was SSI
whereby the rate increased significantly (p-value < 0.05)
when comparing the year 2014 to 2015 (Table 1 and Fig.
1). Between both years, no intervention was introduced
in terms of recommendations to improve upon infection
control practices which may have been one of the reason
there were no observed decrease in device-associated
HAI rates. This high incidence of HAI associated with
SSI was due to the fact that the Astana NRCOT is a
multidisciplinary hospital focusing on multiple types of
surgeries. In most cases, patients also had poor nutri-
tional and altered immune status due to devastating dis-
eases, which were either cancer, kidney and liver failure,
diabetes, and coexisting infections at the remote body
site. Multiple studies stated that the above mentioned
medical conditions predispose patients to the develop-
ment of SSI [20, 21]. Medical procedures in the hospital
were typically prolonged, and patients were prone to in-
traoperative hypothermia, increasing the risk for SSI
[22]. In our setting, colorectal surgery was the most fre-
quently performed surgery, which is recognized as a risk
factor for SSI worldwide [23].
From our study, VAP was identified as the second
most common type of HAI. For patients on mechanical
ventilation however, VAP was the leading type of infec-
tion, which is consistent with reports from multiple
other studies [24, 25]. Majority of the patients who de-
veloped VAP had COPD, advanced age, H2-antagonists
and antibiotics use, and Multiple Organ System Failure
[26]. Similar to the SSI associated HAI described above,
the rates of VAP also increased significantly when com-
paring 2014 to 2015 (Table 1 and Fig. 1); this may have
also been due to absence of intervention that was im-
plemented to reduce the number of VAP cases in the
studied ICU. The third most common type of HAI
identified in our study was BSI. Almost all patients who
developed BSI had the following risk factors; central
vein catheterization, malnutrition and surgery, and in-
fection with highly antibiotic resistant pathogens.
These findings are supported by evidence from other
studies, which report BSI to occur in 5% of all ICU
patients [26, 27].
We found that HAI were predominantly caused by
gram-negative pathogens, including P. aeruginosa, K.
pneumoniae, and E. coli. These strains were most fre-
quently associated with VAP, SSI, BSI and UTI. From
our study, P. aeruginosa was recognized as a causal
agent of the most serious HAI in the ICU [28]. This
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organism was also causing the majority of VAP and BSI
in two consecutive years [9]. SSI analogously was mainly
caused by gram-negative bacteria, of which P. aeruginosa
prevailed in 2014, while K. pneumoniae predominated in
2015. Another interesting finding was with regards to
the differences between the length of ICU patient stay,
the patient population type, rate of HAI as well as the
types of pathogens isolated in 2014 when compared to
2015. Since the period of ICU stay of patients after
emergency surgeries was much shorter than after onco-
logical or transplant surgeries, the overall period of ICU
stay was longer in 2015. Furthermore, ICU patients’ gen-
eral condition was better among patients in 2014. Our
results showed that the rate of HAIs was increased and
the distribution of pathogen also changed in 2015 com-
pared to 2014. We propose that the difference between
patient populations in the ICU partially explained the
reason for increased number and rates of HAI in 2015
(Table 1 and Fig. 1), as well as the differences in the
types of HAI pathogens that were isolated when these
pathogen types were compared between the two years of
study. With regards to increased HAI rate, both the
oncological and transplant patient populations were im-
munocompromised due to the surgical procedures, and
these patients also received immunosuppressant drugs;
this led to further decrease in their immune status. Plus,
these patients stayed longer in the ICU thereby had
higher risk of acquiring ICU-related HAIs. Interestingly,
more HAI pathogens that are more commonly associated
with multidrug resistance belonging to the “ESKAPE”
pathogen group were identified in 2015. This included P.
aeruginosa, E. faecalis, K. pneumoniae and A. baumannii
(Fig. 2); this is not a surprising finding given that these
pathogens are associated with many HAI infections within
the last few decades [29].
There are limitations to this study, which include the
fact that data collected did not include patients’ age, sex,
and other demographic variables, which might have con-
tributed towards generation of more precise and valu-
able conclusions. For future studies, the design could
include collection of these and other relevant informa-
tion that would enhance the quality of data and conclu-
sions that can be derived from the study. In this study,
some organisms identified were usually not considered
common causative agents (such as Candida, Entero-
coccus faecalis, Staphylococcus epidermidis and Strepto-
coccus mitis for VAP as in Fig. 3a, and S. epidermidis
and S. viridans for UTI as shown in Fig. 3c). Such unex-
pected findings further support our conclusion that
there is an urgent and definitive need to improve upon
HAI prevention practices which include incorporation of
surveillance protocols that meet international standards
that can more accurately detect and identify the cor-
rect etiological agent (which includes incorporation of
quality control measures and established Standard op-
erating procedure) in Kazakhstan and other developing
countries within the region. These findings indicate that
the surveillance protocols mentioned in the method sec-
tion were not fully implemented during the study period,
which is a major limitation of this study. Therefore the
findings from this study demonstrates the need to im-
prove training of infection control personnel regarding the
use of and implementation of more stringent practices
that meet the international HAI infection control and sur-
veillance guidelines.
HAI is a critical problem for health-care providers
worldwide, which should receive appropriate attention
for further management. The integrated HAI control
program was introduced more than 3 decades ago for
the first time, being able to reduce both incidence of in-
fections and related healthcare costs [30]. Unfortunately,
many developing countries such as Kazakhstan lack sur-
veillance systems which could effectively decrease inci-
dence of HAIs and healthcare costs for their treatment.
Currently, the international guidelines on prevention,
diagnosis and treatment of HAI are not actively prac-
ticed, and access to newer antibacterial agents is not
readily available in Kazakhstan. Within Kazakhstan,
there are National and Regional Medical Centers (hos-
pitals). There are no published epidemiological data
on HAI from the Regional Medical Centers, therefore,
the epidemiological characteristics of HAI from these
Centers are unknown. If we compare the National
Medical Centers with Regional hospitals, there is an
unequal supply of medical equipment and uneven
qualification of medical doctors and staff in the latter.
For example, several National Medical Centers have
internationally educated doctors and staff as well as
equipment resembling those that can be found in the
best World Class Medical Centers. These medical
Centers can be effective in monitoring, diagnosing, treat-
ing and preventing the HAI, whereas many Regional (and
rural) hospitals do not even follow any guidelines on diag-
nosis, treatment and preventions of HAIs. The National
Medical Centers frequently receive severely ill patients
with multiple undiagnosed multi- and pandrug resistant
HAI from the Regional Medical Centers.
We propose that the most important recommended
measures to prevent HAI at the NRCOT and similar
Healthcare Institutions are rational antibacterial therapy,
regular infection control audits, and general hygiene
measures. Numerous studies in developing countries
have shown that the International Nosocomial Infection
Control Consortium (INICC) multidimensional infection
control strategy with practice bundles can decrease the
rate of HAI. Rosenthal et al. found that implementation
of a multidimensional infection control strategy can sig-
nificantly reduce the central line-associated BSI rates in
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the PICUs of developing countries [31]. In another
study, Tao et al. demonstrated that a multidimensional
infection control intervention for VAP contributed to a
significant cumulative reduction in the VAP rate in their
ICUs [32].
This is a first surveillance study on HAI at the
NRCOT since its foundation eight years ago. An active
surveillance system monitoring incidence and prevalence
of HAI as preventative measures is necessary, and this
study represents a first step towards this goal.
Conclusions
We conclude that HAI is one of the major problems in
healthcare provision in Kazakhstan. SSI, VAP and BSI
are the predominant types of HAI. Gram-negative bac-
teria such as P. aeruginosa, K. pneumoniae and E. coli
are the most common causative agents of HAI. The
most important risk factors are advanced age, severity of
disease, hyperglycemia, neutropenia, immunosuppressive
therapy, cancer diagnosis, and malnutrition. For more
precise determination of its causality, an ongoing HAI
surveillance program is needed to decrease HAI inci-
dence and prevalence at the NRCOT and other health-
care institutions throughout the country. Kazakhstan has
made significant effort and progress since independence
to establish a healthcare system that is already an im-
provement over the centralized Semashko health system
model inherited from the Soviet Union at independence
[19]. One of the ways to continue on the positive trajec-
tory of change for an improved healthcare system is im-
plementation of an efficient active surveillance system
for HAI that should be implemented nationwide. The
system should include an organized and controlled data
collection performed by trained personnel. The data col-
lected should include not only infection-related data, but
also patient-related data such as risk factors and history
of present illness (such as history of HAI, diagnostic
tests, surgeries and invasive methods, as well as the anti-
microbial drugs used). A system of monthly HAI ana-
lysis and report should also be implemented. Such
proactive surveillance system coupled with efficient in-
fection control programs would be highly beneficial to
control and reduce the rates of HAI within all Regional
and National Medical Centers throughout Kazakhstan.
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